The successful sourcing, generation and analysis of data has fast become the backbone behind what makes a pharma company tick.
It’s a process spreading its wings throughout the company, from drug discovery to post-approval, imposing the necessity of creating evidence for effective value demonstration to meet payor needs on all. It marks a movement in the goal posts of success for a modern-day pharma company.
This new revolution will not be forged in the belly of R&D; now is the time for those working in access, data, medical and evidence generation to take the next leap forward.
At Data, Evidence, Access 2017 over 250+ pharma executives will be brought together to plot the next stages of this movement. Pre-order the brochure to make sure you’re kept up-to-date with the latest developments.